Insights

Innovative Product Launches Geistlich Pharma North America continually expands its product portfolio with innovative regenerative solutions, such as the recent launches of Micross Curve and SafeScraper TWIST VOLUMIZER. These new offerings present opportunities to engage healthcare providers seeking cutting-edge tissue regeneration technologies.

Strategic Acquisitions The company's acquisition of Lynch Biologics indicates a focus on biologics and tissue engineering, suggesting potential sales avenues for advanced regenerative materials and biologic products to clinics and hospitals invested in tissue regeneration.

Growing Market Presence With a revenue between $25M and $50M and a global footprint through subsidiaries, Geistlich Pharma is positioned as a leader in regenerative dentistry, making it a prime partner for dental practices and implant centers looking for reliable, high-quality biomaterials.

Leadership in Regenerative Medicine As a leader in oral regeneration with a broad portfolio of membranes, grafts, and matrices, the company offers tailored solutions that can meet the evolving needs of dental surgeons and specialists, opening opportunities for targeted product collaborations and institutional sales.

Market Trend Alignment The company's focus on scientific collaboration, manufacturing excellence, and new product development aligns with the increasing demand for minimally invasive, biologically compatible regenerative options in dentistry, positioning Geistlich Pharma to capitalize on rising market trends and emerging clinical needs.

Geistlich Pharma North America, Inc. Tech Stack

Geistlich Pharma North America, Inc. uses 8 technology products and services including Open Graph, Lodash, jQuery, and more. Explore Geistlich Pharma North America, Inc.'s tech stack below.

  • Open Graph
    Content Management System
  • Lodash
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Priority Hints
    Performance
  • Yoast SEO
    Search Engines
  • Google Analytics
    Web Analytics
  • ElasticPress
    Web Platform Extensions
  • EmbedSocial
    Widgets

Geistlich Pharma North America, Inc.'s Email Address Formats

Geistlich Pharma North America, Inc. uses at least 2 format(s):
Geistlich Pharma North America, Inc. Email FormatsExamplePercentage
First.Last@geistlich-na.comJohn.Doe@geistlich-na.com
94%
First.Middle@geistlich-na.comJohn.Michael@geistlich-na.com
4%
Fir.Last@geistlich-na.comJoh.Doe@geistlich-na.com
2%

Frequently Asked Questions

Where is Geistlich Pharma North America, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Geistlich Pharma North America, Inc.'s main headquarters is located at 400 Alexander Park Princeton, New Jersey 08540 United States. The company has employees across 1 continents, including North America.

What is Geistlich Pharma North America, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Geistlich Pharma North America, Inc.'s official website is geistlich.us and has social profiles on LinkedIn.

What is Geistlich Pharma North America, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Geistlich Pharma North America, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Geistlich Pharma North America, Inc. have currently?

Minus sign iconPlus sign icon
As of April 2026, Geistlich Pharma North America, Inc. has approximately 53 employees across 1 continents, including North America. Key team members include Chief Executive Officer: R. H.Vice President Of Sales: L. J.Vice President , Sales: D. M.. Explore Geistlich Pharma North America, Inc.'s employee directory with LeadIQ.

What industry does Geistlich Pharma North America, Inc. belong to?

Minus sign iconPlus sign icon
Geistlich Pharma North America, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Geistlich Pharma North America, Inc. use?

Minus sign iconPlus sign icon
Geistlich Pharma North America, Inc.'s tech stack includes Open GraphLodashjQueryPriority HintsYoast SEOGoogle AnalyticsElasticPressEmbedSocial.

What is Geistlich Pharma North America, Inc.'s email format?

Minus sign iconPlus sign icon
Geistlich Pharma North America, Inc.'s email format typically follows the pattern of First.Last@geistlich-na.com. Find more Geistlich Pharma North America, Inc. email formats with LeadIQ.

When was Geistlich Pharma North America, Inc. founded?

Minus sign iconPlus sign icon
Geistlich Pharma North America, Inc. was founded in 2012.

Geistlich Pharma North America, Inc.

Pharmaceutical ManufacturingNew Jersey, United States51-200 Employees

Geistlich Pharma North America, Inc., is an affiliate of Geistlich Pharma AG who produce and distribute medical devices and pharmaceuticals for regenerative medicine in Wolhusen and Root, Switzerland. The Swiss company forms part of the Geistlich group which has been in family hands since 1851. Geistlich Pharma and its 3 business units Geistlich Biomaterials, Geistlich Surgery, Geistlich Medical have 10 subsidiaries and global distribution, over 500 employees worldwide and is a world leader in regenerative dentistry through its business unit Geistlich Biomaterials. 

Geistlich continues to lead oral regeneration based upon our history of quality, scientific collaboration, and manufacturing excellence. Every Geistlich biomaterial is intentionally designed for a specific application and carefully engineered to preserve its natural structures. Today, our full product portfolio of Bone Substitutes, Membranes, and Matrices increases clinical flexibility and expands treatment options in a variety of therapeutic areas.

Geistlich Bio-Oss®: Derived from bovine bone and preserved through a unique, patented process, making it highly similar to human bone. Geistlich Bio-Oss® remains the essential choice among an expanding range of therapeutic areas through its unique properties and reliable clinical outcomes.

Geistlich Bio-Gide®: A unique bilayer collagen membrane designed to ensure optimal regenerative healing of bone and soft tissue. It provides excellent wound stability and graft containment with optimal protection for bone regeneration.

Geistlich Mucograft®: A collagen matrix designed for gain of keratinized tissue and recession coverage where open healing is required. 

Geistlich Fibro-Gide®: The first volume-stable collagen matrix designed for soft-tissue augmentation around natural teeth and implants as a submerged scaffold where an increase in soft-tissue thickness is clinically desired.

Section iconCompany Overview

Headquarters
400 Alexander Park Princeton, New Jersey 08540 United States
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2012
Employees
51-200

Section iconFunding & Financials

  • $25M$50M

    Geistlich Pharma North America, Inc.'s revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    Geistlich Pharma North America, Inc.'s revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.